Left Ventricular Dysfunction Clinical Trial
Official title:
Administration of Mesenchymal Stem Cells in Patients With Chronic Ischemic Cardiomyopathy
Ischemic cardiomyopathies are a leading cause of death in both men and women. When a person has a heart attack, blood is unable to reach a certain area of the heart, and if the blood supply is not re-established quickly, that area of the heart can suffer permanent damage. While recovery from a heart attack can be managed through medications and lifestyle changes, these treatments can not reverse the all damage to the heart. Current research is focusing on the development of cell-based therapies using stem cells to repair organs that have been irreversibly damaged by disease. A specific form of stem cells, called adult mesenchymal stem cells (MSCs), has shown promise for heart repair. This study will evaluate the safety of injecting MSCs directly into the heart to repair and restore heart function in people who have had a heart attack and who have chronic myocardial ischemia with heart failure.
Mesenchymal stem cells from the bone marrow can differentiate into endothelial cells and participate in the development of new blood vessels in ischemic tissue. The aim of the study is in a phase I safety study to evaluate the clinical effect of autologous mesenchymal stem cell therapy in patients with severe chronic myocardial ischemia.10 patients with reversible ischemia on a SPECT will be treated with direct intramyocardial injections of autologous isolated and expanded mesenchymal stem cells.Clinical and objective evaluations will be performed at baseline and during 24 months follow-up. ;
Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Enrolling by invitation |
NCT05529654 -
IMpella-Protected cArdiaC Surgery Trial (IMPACT)
|
N/A | |
| Recruiting |
NCT04671966 -
Sex Differences in Myocardial Steatosis Induced Left Ventricular Dysfunction
|
Phase 4 | |
| Not yet recruiting |
NCT05188222 -
Preoperative Maltodextrin's Effect on Cardiac Function in Cardiac Surgery
|
Phase 4 | |
| Recruiting |
NCT04950218 -
The Psoriasis Echo Study
|
||
| Completed |
NCT01128790 -
Pilot Study of Remote Ischemic Preconditioning in Heart Failure
|
N/A | |
| Completed |
NCT04942353 -
Effects of Home-based Exercise Rehabilitation on Healthcare Utilization in HeartMate 3 Patients
|
N/A | |
| Recruiting |
NCT05769036 -
Conventional Biventricular Versus Left Bundle Branch Pacing on Outcomes in Heart Failure Patients
|
N/A | |
| Completed |
NCT03232736 -
InterventiOn of Biventricular Pacemaker Function on ventrIcular Function Among Patients With LVAD's
|
||
| Recruiting |
NCT04694092 -
Landiolol for Rate Control in Decompensated Heart Failure Due to Atrial Fibrillation
|
N/A | |
| Completed |
NCT01609738 -
Left Ventricular Septum Pacing in Patients by Transvenous Approach Through the Inter-ventricular Septum
|
Phase 1/Phase 2 | |
| Completed |
NCT02013037 -
The De-novo Use of Eculizumab in Presensitized Patients Receiving Cardiac Transplantation
|
Phase 3 | |
| Completed |
NCT00551681 -
Effects of Left Ventricular Pacing Optimilization on Cardiac Perfusion, Contractile Force, and Clinical Performance in Patients With Ventricular Dysfunction and Heart Failure
|
N/A | |
| Not yet recruiting |
NCT04103008 -
Left Ventricular Function After Primary Percutaneous Coronary Intervention: Role of Speckle Echocardiography
|
||
| Completed |
NCT06197256 -
Cardiac Dysfunction in Critically Ill Covid-19 Patients
|
||
| Recruiting |
NCT05860504 -
Acute Cardiac Dysfunction in Critical Illnes
|
||
| Completed |
NCT03787810 -
Left Ventricular Dysfunction in Critically Ill Patients
|
||
| Completed |
NCT01093001 -
Tricuspid Regurgitation Study
|
Phase 4 | |
| Active, not recruiting |
NCT00461734 -
PROTECT-PACE STUDY - The Protection of Left Ventricular Function During Right Ventricular Pacing
|
N/A | |
| Recruiting |
NCT04752293 -
Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)
|
||
| Not yet recruiting |
NCT05760924 -
Left Bundle Branch Pacing on Outcomes and Ventricular Remodeling in Biventricular CRT Nonresponders
|
N/A |